id	sid	eid	entity	type
ajlm-1296	1	1	asmaa m. zahran	PERSON
ajlm-1296	1	2	south egypt	GPE
ajlm-1296	1	3	assiut university	ORG
ajlm-1296	1	4	assiut	GPE
ajlm-1296	1	5	egypt	GPE
ajlm-1296	1	6	nafady-hego	PERSON
ajlm-1296	1	7	assiut university	ORG
ajlm-1296	1	8	assiut	GPE
ajlm-1296	1	9	egypt	GPE
ajlm-1296	1	10	m. moeen department of internal medicine	ORG
ajlm-1296	1	11	assiut university	ORG
ajlm-1296	1	12	assiut	GPE
ajlm-1296	1	13	egypt	GPE
ajlm-1296	1	14	hanan a. eltyb	PERSON
ajlm-1296	1	15	south egypt	GPE
ajlm-1296	1	16	assiut university assiut	ORG
ajlm-1296	1	17	egypt	GPE
ajlm-1296	1	18	mohammed m. wahman department	PERSON
ajlm-1296	1	19	south valley university	ORG
ajlm-1296	1	20	qena	GPE
ajlm-1296	1	21	egypt	GPE
ajlm-1296	1	22	south valley university	ORG
ajlm-1296	1	23	qena	GPE
ajlm-1296	1	24	egypt	GPE
ajlm-1296	1	25	nafady-hego	PERSON
ajlm-1296	1	26	moeen sm	PERSON
ajlm-1296	1	27	wahman mm	PERSON
ajlm-1296	1	28	nafady a.	PERSON
ajlm-1296	1	29	egypt	GPE
ajlm-1296	2	1	afr j	PERSON
ajlm-1296	3	1	2021;10(1	CARDINAL
ajlm-1296	3	2	egypt	GPE
ajlm-1296	3	3	asmaa m. zahran	PERSON
ajlm-1296	3	4	nafady-hego	PERSON
ajlm-1296	3	5	sawsan m. moeen	PERSON
ajlm-1296	3	6	hanan a. eltyb	PERSON
ajlm-1296	3	7	mohammed m. wahman	PERSON
ajlm-1296	3	8	asmaa nafady	PERSON
ajlm-1296	3	9	09	CARDINAL
ajlm-1296	3	10	11	CARDINAL
ajlm-1296	4	1	25	CARDINAL
ajlm-1296	4	2	aug. 2021	DATE
ajlm-1296	4	3	2021	CARDINAL
ajlm-1296	11	1	20	CARDINAL
ajlm-1296	11	2	assiut	GPE
ajlm-1296	11	3	egypt	GPE
ajlm-1296	11	4	between october 2018	DATE
ajlm-1296	11	5	august 2019	DATE
ajlm-1296	11	6	cd14	PRODUCT
ajlm-1296	11	7	cd16	PRODUCT
ajlm-1296	12	1	20	CARDINAL
ajlm-1296	13	1	mm	PERSON
ajlm-1296	13	2	±	CARDINAL
ajlm-1296	13	3	77.24 ± 0.66	MONEY
ajlm-1296	13	4	83.75 ± 0.5	MONEY
ajlm-1296	13	5	12.44 ± 0.5	MONEY
ajlm-1296	13	6	8.9 ± 0.34	QUANTITY
ajlm-1296	13	7	10.3 ± 0.24	QUANTITY
ajlm-1296	13	8	7.4 ± 0.29	QUANTITY
ajlm-1296	14	1	0.0001	CARDINAL
ajlm-1296	19	1	mm	PERSON
ajlm-1296	21	1	cd16	ORG
ajlm-1296	21	2	cd14	ORG
ajlm-1296	21	3	three	CARDINAL
ajlm-1296	21	4	mm patients.16	FAC
ajlm-1296	21	5	mm	PERSON
ajlm-1296	21	6	monocyte	PERSON
ajlm-1296	21	7	mm	PERSON
ajlm-1296	22	1	mm detection,17	PERSON
ajlm-1296	23	1	the assiut university hospital	ORG
ajlm-1296	23	2	assiut	GPE
ajlm-1296	23	3	egypt	GPE
ajlm-1296	24	1	assiut university	ORG
ajlm-1296	24	2	37:10/1/2018	DATE
ajlm-1296	25	1	helsinki	ORG
ajlm-1296	27	1	helsinki	ORG
ajlm-1296	31	1	internal medicine department	ORG
ajlm-1296	31	2	assiut university hospital	ORG
ajlm-1296	31	3	south egypt	GPE
ajlm-1296	31	4	assiut university	ORG
ajlm-1296	31	5	assiut	GPE
ajlm-1296	31	6	egypt	GPE
ajlm-1296	31	7	october 2018	DATE
ajlm-1296	32	1	twenty	CARDINAL
ajlm-1296	32	2	the world health organization criteria	ORG
ajlm-1296	32	3	mm	PERSON
ajlm-1296	32	4	20	CARDINAL
ajlm-1296	34	1	three	CARDINAL
ajlm-1296	35	1	less than 10.5 mg	QUANTITY
ajlm-1296	35	2	jones	PERSON
ajlm-1296	35	3	4	CARDINAL
ajlm-1296	35	4	g/24	ORG
ajlm-1296	35	5	i. stage ii	PERSON
ajlm-1296	36	1	one	CARDINAL
ajlm-1296	36	2	jones	PERSON
ajlm-1296	36	3	12	CARDINAL
ajlm-1296	36	4	g/24	ORG
ajlm-1296	36	5	3	CARDINAL
ajlm-1296	36	6	less than 3.5 mg/l	TIME
ajlm-1296	36	7	less than 3.5 mg/l	TIME
ajlm-1296	36	8	less than 3.5	CARDINAL
ajlm-1296	36	9	between 3.5 mg/l and 5.5 mg/l	QUANTITY
ajlm-1296	36	10	5.5 mg/l	QUANTITY
ajlm-1296	39	1	abbott diagnostics	ORG
ajlm-1296	39	2	chicago	GPE
ajlm-1296	39	3	illinois	GPE
ajlm-1296	39	4	united states	GPE
ajlm-1296	41	1	400	CARDINAL
ajlm-1296	41	2	gmbh	GPE
ajlm-1296	41	3	mannheim	GPE
ajlm-1296	41	4	germany	GPE
ajlm-1296	41	5	500558	CARDINAL
ajlm-1296	42	1	rome	GPE
ajlm-1296	42	2	italy	GPE
ajlm-1296	42	3	38405301	DATE
ajlm-1296	44	1	mm	PERSON
ajlm-1296	45	1	fifty	CARDINAL
ajlm-1296	45	2	5	CARDINAL
ajlm-1296	45	3	cd14	PRODUCT
ajlm-1296	45	4	cd16	ORG
ajlm-1296	45	5	becton dickinson	PERSON
ajlm-1296	46	1	san jose	GPE
ajlm-1296	46	2	california	GPE
ajlm-1296	46	3	united states	GPE
ajlm-1296	47	1	15 min	QUANTITY
ajlm-1296	48	1	facscalibur	NORP
ajlm-1296	48	2	san jose	GPE
ajlm-1296	48	3	california	GPE
ajlm-1296	48	4	united states	GPE
ajlm-1296	48	5	san jose	GPE
ajlm-1296	48	6	california	GPE
ajlm-1296	48	7	united states	GPE
ajlm-1296	51	1	cd14	PRODUCT
ajlm-1296	51	2	cd16	PRODUCT
ajlm-1296	52	1	1	CARDINAL
ajlm-1296	53	1	monocyte	PERSON
ajlm-1296	54	1	1	CARDINAL
ajlm-1296	54	2	monocyte	PERSON
ajlm-1296	54	3	assiut university	ORG
ajlm-1296	54	4	assiut	GPE
ajlm-1296	54	5	egypt	GPE
ajlm-1296	54	6	october 2018	DATE
ajlm-1296	57	1	cd16-phycoerythrin	PRODUCT
ajlm-1296	58	1	±	CARDINAL
ajlm-1296	58	2	77.24 ± 0.66	MONEY
ajlm-1296	58	3	83.75 ± 0.5	MONEY
ajlm-1296	58	4	0.0001	CARDINAL
ajlm-1296	58	5	12.44 ± 0.5	MONEY
ajlm-1296	58	6	8.9 ± 0.34	QUANTITY
ajlm-1296	58	7	0.0001	CARDINAL
ajlm-1296	58	8	10.3 ± 0.24	MONEY
ajlm-1296	58	9	7.4 ± 0.29	QUANTITY
ajlm-1296	58	10	0.0001	CARDINAL
ajlm-1296	59	1	21	CARDINAL
ajlm-1296	59	2	ibm	ORG
ajlm-1296	59	3	armonk	GPE
ajlm-1296	59	4	new york	GPE
ajlm-1296	59	5	united states	GPE
ajlm-1296	60	1	±	CARDINAL
ajlm-1296	61	1	mann-whitney	PERSON
ajlm-1296	63	1	0.05	CARDINAL
ajlm-1296	64	1	6.35 ±	MONEY
ajlm-1296	64	2	4.07 years	DATE
ajlm-1296	64	3	13	CARDINAL
ajlm-1296	64	4	7	CARDINAL
ajlm-1296	64	5	1	CARDINAL
ajlm-1296	65	1	39.7 ± 3.7%	PERCENT
ajlm-1296	65	2	4.44 ± 2.8	QUANTITY
ajlm-1296	65	3	1	CARDINAL
ajlm-1296	65	4	assiut	GPE
ajlm-1296	65	5	egypt	GPE
ajlm-1296	65	6	october 2018	DATE
ajlm-1296	65	7	august 2019	DATE
ajlm-1296	66	1	0.05	CARDINAL
ajlm-1296	67	1	9.3 ± 2.4	MONEY
ajlm-1296	67	2	mm	PERSON
ajlm-1296	67	3	12.8 ±	MONEY
ajlm-1296	67	4	0.045	CARDINAL
ajlm-1296	67	5	2.46 ± 0.9	QUANTITY
ajlm-1296	67	6	mm	PERSON
ajlm-1296	67	7	4.63 ± 1.1	MONEY
ajlm-1296	67	8	0.0001	CARDINAL
ajlm-1296	68	1	11.75 ± 0.4 mg	MONEY
ajlm-1296	68	2	mm	PERSON
ajlm-1296	68	3	8.8 ± 0.1 mg	QUANTITY
ajlm-1296	68	4	0.0001	CARDINAL
ajlm-1296	68	5	886.86 ± 92.6	CARDINAL
ajlm-1296	68	6	155.8 ±	CARDINAL
ajlm-1296	68	7	8.23	MONEY
ajlm-1296	68	8	0.0001	CARDINAL
ajlm-1296	68	9	1.9 ± 0.2 mg	MONEY
ajlm-1296	68	10	mm	PERSON
ajlm-1296	68	11	0.97 ± 0.1 mg	MONEY
ajlm-1296	68	12	0.0001	CARDINAL
ajlm-1296	69	1	12	CARDINAL
ajlm-1296	69	2	60%	PERCENT
ajlm-1296	69	3	20	CARDINAL
ajlm-1296	69	4	6/20	CARDINAL
ajlm-1296	69	5	30%	PERCENT
ajlm-1296	69	6	2/20	CARDINAL
ajlm-1296	69	7	10%	PERCENT
ajlm-1296	70	1	70%	PERCENT
ajlm-1296	70	2	20%	PERCENT
ajlm-1296	70	3	10%	PERCENT
ajlm-1296	70	4	2	CARDINAL
ajlm-1296	71	1	cd16	PRODUCT
ajlm-1296	71	2	cd14	ORG
ajlm-1296	73	1	83.8%	PERCENT
ajlm-1296	73	2	8.9%	PERCENT
ajlm-1296	73	3	7.4%	PERCENT
ajlm-1296	74	1	77.24%	PERCENT
ajlm-1296	74	2	83.75%	PERCENT
ajlm-1296	74	3	12.44%	PERCENT
ajlm-1296	74	4	8.9%	PERCENT
ajlm-1296	74	5	10.3%	PERCENT
ajlm-1296	74	6	7.4%	PERCENT
ajlm-1296	74	7	0.0001	CARDINAL
ajlm-1296	74	8	1	CARDINAL
ajlm-1296	75	1	monocyte	PERSON
ajlm-1296	75	2	0.731	CARDINAL
ajlm-1296	75	3	0.0001	CARDINAL
ajlm-1296	75	4	0.389	CARDINAL
ajlm-1296	75	5	0.0001	CARDINAL
ajlm-1296	75	6	0.545	CARDINAL
ajlm-1296	75	7	0.0010	CARDINAL
ajlm-1296	75	8	0.582	CARDINAL
ajlm-1296	75	9	0.0001	CARDINAL
ajlm-1296	75	10	0.222	CARDINAL
ajlm-1296	75	11	0.005	CARDINAL
ajlm-1296	75	12	0.347	CARDINAL
ajlm-1296	75	13	0.0001	CARDINAL
ajlm-1296	75	14	2	CARDINAL
ajlm-1296	76	1	2	CARDINAL
ajlm-1296	76	2	assiut university	ORG
ajlm-1296	76	3	assiut	GPE
ajlm-1296	76	4	egypt	GPE
ajlm-1296	76	5	october 2018	DATE
ajlm-1296	77	1	0.731	CARDINAL
ajlm-1296	77	2	0.0001	CARDINAL
ajlm-1296	77	3	0.389	CARDINAL
ajlm-1296	77	4	0.0001	CARDINAL
ajlm-1296	77	5	0.545	CARDINAL
ajlm-1296	77	6	0.0001	CARDINAL
ajlm-1296	77	7	0.582	CARDINAL
ajlm-1296	77	8	0.0001	CARDINAL
ajlm-1296	77	9	0.222	CARDINAL
ajlm-1296	77	10	0.05	CARDINAL
ajlm-1296	77	11	0.347	CARDINAL
ajlm-1296	77	12	0.005	CARDINAL
ajlm-1296	78	1	0.624	CARDINAL
ajlm-1296	78	2	0.0001	CARDINAL
ajlm-1296	78	3	0.413	CARDINAL
ajlm-1296	78	4	0.0001	CARDINAL
ajlm-1296	78	5	0.533	CARDINAL
ajlm-1296	78	6	0.0001	CARDINAL
ajlm-1296	78	7	0.575	CARDINAL
ajlm-1296	78	8	0.0001	CARDINAL
ajlm-1296	78	9	0.28	CARDINAL
ajlm-1296	78	10	0.024	CARDINAL
ajlm-1296	78	11	0.27	CARDINAL
ajlm-1296	78	12	0.018	CARDINAL
ajlm-1296	78	13	3	CARDINAL
ajlm-1296	79	1	3	CARDINAL
ajlm-1296	79	2	assiut university	ORG
ajlm-1296	79	3	assiut	GPE
ajlm-1296	79	4	egypt	GPE
ajlm-1296	79	5	october 2018	DATE
ajlm-1296	80	1	0.624	CARDINAL
ajlm-1296	80	2	0.0001	CARDINAL
ajlm-1296	80	3	0.413	CARDINAL
ajlm-1296	80	4	0.0001	CARDINAL
ajlm-1296	81	1	0.533	CARDINAL
ajlm-1296	81	2	0.0001	CARDINAL
ajlm-1296	81	3	0.575	CARDINAL
ajlm-1296	81	4	0.0001	CARDINAL
ajlm-1296	81	5	0.28	CARDINAL
ajlm-1296	81	6	0.024	CARDINAL
ajlm-1296	81	7	0.27	CARDINAL
ajlm-1296	81	8	0.018	CARDINAL
ajlm-1296	82	1	0.649	CARDINAL
ajlm-1296	82	2	0.0001	CARDINAL
ajlm-1296	82	3	0.222	CARDINAL
ajlm-1296	82	4	0.002	CARDINAL
ajlm-1296	82	5	0.338	CARDINAL
ajlm-1296	82	6	0.0001	CARDINAL
ajlm-1296	82	7	0.398	CARDINAL
ajlm-1296	82	8	0.0001	CARDINAL
ajlm-1296	82	9	0.301	CARDINAL
ajlm-1296	82	10	0.016	CARDINAL
ajlm-1296	82	11	4	CARDINAL
ajlm-1296	83	1	4	CARDINAL
ajlm-1296	83	2	assiut university	ORG
ajlm-1296	83	3	assiut	GPE
ajlm-1296	83	4	egypt	GPE
ajlm-1296	83	5	october 2018	DATE
ajlm-1296	84	1	0.649	CARDINAL
ajlm-1296	84	2	0.0001	CARDINAL
ajlm-1296	84	3	0.222	CARDINAL
ajlm-1296	84	4	0.002	CARDINAL
ajlm-1296	84	5	0.338	CARDINAL
ajlm-1296	84	6	0.0001	CARDINAL
ajlm-1296	84	7	0.398	CARDINAL
ajlm-1296	84	8	0.0001	CARDINAL
ajlm-1296	84	9	0.301	CARDINAL
ajlm-1296	84	10	0.016	CARDINAL
ajlm-1296	85	1	mm	PERSON
ajlm-1296	89	1	20	CARDINAL
ajlm-1296	90	1	cd14	PRODUCT
ajlm-1296	90	2	cd16	PRODUCT
ajlm-1296	91	1	2015	CARDINAL
ajlm-1296	91	2	france	GPE
ajlm-1296	91	3	cd16	PRODUCT
ajlm-1296	91	4	20 mm	QUANTITY
ajlm-1296	91	5	norway	GPE
ajlm-1296	91	6	2015	DATE
ajlm-1296	91	7	myeloma cells.16	ORG
ajlm-1296	92	1	mm	PERSON
ajlm-1296	93	1	1,21	DATE
ajlm-1296	93	2	cd16	PRODUCT
ajlm-1296	94	1	1	CARDINAL
ajlm-1296	96	1	mm patients.14	ORG
ajlm-1296	96	2	monocyte	PERSON
ajlm-1296	97	1	0.045	CARDINAL
ajlm-1296	97	2	0.0001	CARDINAL
ajlm-1296	97	3	0.0001	CARDINAL
ajlm-1296	98	1	austria	GPE
ajlm-1296	98	2	2010	DATE
ajlm-1296	98	3	mm	PERSON
ajlm-1296	98	4	the united states	GPE
ajlm-1296	98	5	1982,23	CARDINAL
ajlm-1296	98	6	mm	PERSON
ajlm-1296	99	1	0.0001	CARDINAL
ajlm-1296	99	2	0.0001	CARDINAL
ajlm-1296	99	3	39.7 ± 3.7%	PERCENT
ajlm-1296	99	4	44.4 ± 2.8	QUANTITY
ajlm-1296	99	5	one	CARDINAL
ajlm-1296	104	1	h.a.e.	GPE
ajlm-1296	107	1	flowcytometric	ORDINAL
ajlm-1296	113	1	kyle ra	PERSON
ajlm-1296	116	1	2007;139(5):717–723	CARDINAL
ajlm-1296	116	2	de magalhaes rj	PERSON
ajlm-1296	116	3	paiva	PERSON
ajlm-1296	119	1	2013;98(1):79–86	CARDINAL
ajlm-1296	120	1	https://doi.org/10.3324/haematol.2012.067272 suyani e	PERSON
ajlm-1296	121	1	ann hematol	PERSON
ajlm-1296	122	1	2013;92(5):669–677	CARDINAL
ajlm-1296	123	1	kim j	PERSON
ajlm-1296	124	1	j haematol	PERSON
ajlm-1296	125	1	2012;158(3):336–346	CARDINAL
ajlm-1296	125	2	vacca	GPE
ajlm-1296	125	3	ria r	PERSON
ajlm-1296	126	1	chem immunol	PERSON
ajlm-1296	127	1	2014;99:180–196	LANGUAGE
ajlm-1296	128	1	zheng y	PERSON
ajlm-1296	129	1	wang s	PERSON
ajlm-1296	132	1	2009;114(17):3625–3628	CARDINAL
ajlm-1296	133	1	https://doi.org/10.1182/blood-2009-05-220285	GPE
ajlm-1296	133	2	singh av	GPE
ajlm-1296	136	1	2009;16(4):309–323	CARDINAL
ajlm-1296	136	2	flad	PERSON
ajlm-1296	136	3	m. heterogeneity	PERSON
ajlm-1296	138	1	2001;69(1):11–20	CARDINAL
ajlm-1296	139	1	ziegler-heitbrock l.	PERSON
ajlm-1296	140	1	j leukoc	PERSON
ajlm-1296	141	1	2007;81(3):584–592	CARDINAL
ajlm-1296	142	1	cros j	GPE
ajlm-1296	142	2	cagnard n	PERSON
ajlm-1296	143	1	cd14dim	PRODUCT
ajlm-1296	145	1	2010;33(3):375–386	CARDINAL
ajlm-1296	145	2	cooper dl	PERSON
ajlm-1296	145	3	martin sg	PERSON
ajlm-1296	145	4	robinson ji	PERSON
ajlm-1296	146	1	plos one	PERSON
ajlm-1296	147	1	2012;7(1):e28918	CARDINAL
ajlm-1296	148	1	chiu yg	PERSON
ajlm-1296	148	2	shao t	PERSON
ajlm-1296	148	3	feng c	ORG
ajlm-1296	149	1	cd16	PRODUCT
ajlm-1296	152	1	belge ku	PERSON
ajlm-1296	152	2	dayyani f	PERSON
ajlm-1296	153	1	cd14+cd16+dr++	ORG
ajlm-1296	153	2	tnf	CARDINAL
ajlm-1296	154	1	j immunol	PERSON
ajlm-1296	155	1	2002;168(7):3536–3542	CARDINAL
ajlm-1296	156	1	https://doi.org/10.4049/jimmunol.168.7.3536 sponaas am	PERSON
ajlm-1296	156	2	liabakk nb	PERSON
ajlm-1296	158	1	immun inflamm	PERSON
ajlm-1296	160	1	https://doi.org/10.1002/iid3.53 petitprez	PERSON
ajlm-1296	160	2	royer b	ORG
ajlm-1296	160	3	desoutter jp	PERSON
ajlm-1296	161	1	cd14+ cd51/61	GPE
ajlm-1296	164	1	2015;37(1):29–35	CARDINAL
ajlm-1296	164	2	robey pg	PERSON
ajlm-1296	165	1	rev mol diagn	PERSON
ajlm-1296	166	1	2010;10(4):465–480	CARDINAL
ajlm-1296	166	2	pillay s	PERSON
ajlm-1296	166	3	wilson dpk	PERSON
ajlm-1296	167	1	kwazulu	GPE
ajlm-1296	167	2	south africa	GPE
ajlm-1296	168	1	afr j	PERSON
ajlm-1296	173	1	1975;36(3):842–854	CARDINAL
ajlm-1296	174	1	san miguel j	PERSON
ajlm-1296	174	2	durie bg	PERSON
ajlm-1296	176	1	j clin oncol	PERSON
ajlm-1296	177	1	2005;23(15):3412–3420	CARDINAL
ajlm-1296	179	1	tucci m	PERSON
ajlm-1296	179	2	interleukin-17a	CARDINAL
ajlm-1296	181	1	2013;161(6):821–831	CARDINAL
ajlm-1296	182	1	sundan a.	PERSON
ajlm-1296	184	1	2014;25(3):343–350	CARDINAL
ajlm-1296	185	1	ludwig h	ORG
ajlm-1296	185	2	bladé j	PERSON
ajlm-1296	186	1	european	NORP
ajlm-1296	188	1	2010;15(1):6–25	CARDINAL
ajlm-1296	188	2	durie bg	PERSON
ajlm-1296	190	1	clin haematol	PERSON
ajlm-1296	191	1	1982;11(1):181–210	CARDINAL
ajlm-1296	192	1	alexanian	NORP
ajlm-1296	192	2	dixon d. renal	PERSON
ajlm-1296	196	1	https://doi.org/10.1001/archinte.1990.00040031693017 dimopoulos ma	PERSON
ajlm-1296	196	2	kastritis e	PERSON
ajlm-1296	196	3	rosinol l	ORG
ajlm-1296	200	1	simonsson	PERSON
ajlm-1296	200	2	brenning g	PERSON
ajlm-1296	202	1	j clin	PERSON
ajlm-1296	203	1	1987;17(4):336–339	CARDINAL